title: rFVIIa (Novoseven): the new panacea?
authors.affiliation: Anaesthesiology Department, Hôpital Erasme, 808, route de Lennik, 1070 Bruxelles.
authors.forename: B E
authors.initials: BE
authors.lastname: Ickx
mesh_terms: D005167:Factor VII / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D015942:Factor VIIa; D006467:Hemophilia A / Q000188:drug therapy*; D006470:Hemorrhage / Q000517:prevention & control*; D006801:Humans; D011994:Recombinant Proteins / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*
chemical_list: D011994:Recombinant Proteins; D005167:Factor VII; C103587:recombinant FVIIa; D015942:Factor VIIa